Protalix BioTherapeutics Market Cap

Protalix BioTherapeutics has a market cap or net worth of $86.20 million as of April 25, 2024. Its market cap has decreased by -38.38% in one year.

Market Cap

86.20M

Enterprise Value

67.92M

1-Year Change

-38.38%

Ranking

#4203

Market Cap Chart

Since December 1, 1998, Protalix BioTherapeutics's market cap has increased from $11.80M to $86.20M, an increase of 630.52%. That is a compound annual growth rate of 8.14%.

Market Cap History

Date	Market Cap	% Change
Apr 24, 2024	88.40M	0.80%
Apr 23, 2024	87.70M	1.74%
Apr 22, 2024	86.20M	2.62%
Apr 19, 2024	84.00M	1.82%
Apr 18, 2024	82.50M	-1.79%
Apr 17, 2024	84.00M	0.84%
Apr 16, 2024	83.30M	-
Apr 15, 2024	83.30M	-3.36%
Apr 12, 2024	86.20M	-3.25%
Apr 11, 2024	89.10M	-3.15%
Apr 10, 2024	92.00M	-4.56%
Apr 9, 2024	96.40M	1.47%
Apr 8, 2024	95.00M	11.11%
Apr 5, 2024	85.50M	-3.28%
Apr 4, 2024	88.40M	-2.43%
Apr 3, 2024	90.60M	-
Apr 2, 2024	90.60M	-0.77%
Apr 1, 2024	91.30M	-0.76%
Mar 28, 2024	92.00M	0.77%
Mar 27, 2024	91.30M	2.47%
Mar 26, 2024	89.10M	-
Mar 25, 2024	89.10M	-3.99%
Mar 22, 2024	92.80M	-3.73%
Mar 21, 2024	96.40M	-1.53%
Mar 20, 2024	97.90M	3.05%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Milestone Pharmaceuticals	89.56M
111, Inc.	89.36M
The Oncology Institute	89.18M
Abeona Therapeutics	88.90M
Curis	88.47M
SELLAS Life Sciences Group	88.34M
SHL Telemedicine	88.19M
TRACON Pharmaceuticals	87.82M

Market Cap Rankings